We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Specialist reference laboratory services for mycobacteriology available in the UK.
When tests to detect COVID-19 are commonly used (use cases) and what to consider when deciding which type of test to employ.
UK Health Security Agency's laboratories provide a comprehensive range of microbiological tests and services.
This test requirement applies only to electrical and electronic equipment where immunity to RF (radio frequency) interference is of principal importance.
Form S9 for requesting HIV genotypic resistance testing from the UK Health Security Agency 's antiviral unit (AVU).
A range of tests are available from the majority of PHE regional clinical microbiology laboratories.
Clinicians are provided with actions to complete when managing infectious diseases in the asylum seeker population.
Summarises incidence and mechanisms of NAI resistance in seasonal influenza viruses and availability of NAI susceptibility testing in UK.
The mycology reference laboratory (MRL) provides a comprehensive laboratory service for the diagnosis and management of fungal infections.
AMRHAI (antimicrobial resistance and healthcare associated infections) is the national reference unit for investigating AMR in healthcare-associated bacteria.
Study involving review of electronic patient-records maintained under Revised National TB Control Programme
Form S15 for requesting HCV genotypic susceptibility testing from UK Health Security Agency's antiviral unit (AVU).
A qualitative study from programmatic setting in India
This paper examines evidence from 21 studies, 11 of which were in low-income or middle-income countries
Form (Y1) for isolates of mould or yeast for identification and antifungal susceptibility testing.
How to support patients in accessing population screening programmes and obtaining screening results.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.